OrthoTrophix completed the dose-finding portion of phase 2 clinical study of TPX-100, its cartilage repair therapeutic agent, in subjects with osteoarthritis of the knee.
↧
OrthoTrophix completed the dose-finding portion of phase 2 clinical study of TPX-100, its cartilage repair therapeutic agent, in subjects with osteoarthritis of the knee.